CNBX Pharmaceuticals Inc.
CNBX
$0.0005
$0.000125.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.42% | 76.03% | 84.39% | 81.26% | 66.59% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -79.23% | -55.34% | -35.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.92% | -93.56% | -93.10% | -91.71% | -76.38% |
| Change in Net Operating Assets | -107.67% | -50.30% | -70.65% | -71.90% | -43.32% |
| Cash from Operations | -8.89% | 28.51% | -139.37% | -117.16% | 37.88% |
| Capital Expenditure | 100.00% | 100.00% | 100.00% | -- | -9.09% |
| Sale of Property, Plant, and Equipment | -100.00% | 373.50% | -- | -- | 326.39% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -100.00% | 403.72% | 388.09% | 359.51% | 125.20% |
| Total Debt Issued | 43.81% | 7.24% | -73.92% | -72.40% | -50.62% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 43.81% | 7.24% | -73.92% | -72.40% | -50.62% |
| Foreign Exchange rate Adjustments | -- | -200.00% | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.10% | 180.19% | -207.17% | -952.89% | 156.13% |